Tolerability and Pharmacokinetic Comparison of Immune Globulin Intravenous (Human) 10% (IGIV, 10%) Administered Intravenously or Subcutaneously in Subjects With Primary Immunodeficiency Diseases

The purpose of this study is to evaluate the tolerability of IGIV, 10% given subcutaneously and the pharmacokinetics of immunoglobulin G (IgG) following subcutaneous (SC) treatment with IGIV, 10% in subjects with primary immunodeficiency (PID) disorders.

本研究旨在评估10% IGIV皮下（Subcutaneous, SC）给药的耐受性，以及原发性免疫缺陷（PID）患者接受10% IGIV皮下治疗后免疫球蛋白G（IgG）的药代动力学特征。